20.62
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AMPH Giù?
Forum
Previsione
Precedente Chiudi:
$21.70
Aprire:
$21.92
Volume 24 ore:
430.24K
Relative Volume:
0.82
Capitalizzazione di mercato:
$972.01M
Reddito:
$723.55M
Utile/perdita netta:
$157.72M
Rapporto P/E:
6.8733
EPS:
3
Flusso di cassa netto:
$170.15M
1 W Prestazione:
-4.80%
1M Prestazione:
-18.63%
6M Prestazione:
-42.24%
1 anno Prestazione:
-48.13%
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Nome
Amphastar Pharmaceuticals Inc
Settore
Telefono
909-980-9484
Indirizzo
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Confronta AMPH con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
AMPH
Amphastar Pharmaceuticals Inc
|
20.62 | 1.02B | 723.55M | 157.72M | 170.15M | 3.00 |
![]()
ZTS
Zoetis Inc
|
148.60 | 68.99B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.43 | 46.36B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
HLN
Haleon Plc Adr
|
9.60 | 44.74B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.06 | 18.81B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
292.01 | 13.33B | 2.99B | 1.21B | 1.13B | 25.06 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-05-12 | Downgrade | JP Morgan | Overweight → Neutral |
2025-02-04 | Downgrade | Piper Sandler | Overweight → Neutral |
2024-11-22 | Iniziato | Wells Fargo | Equal Weight |
2024-03-05 | Iniziato | JP Morgan | Overweight |
2023-11-17 | Iniziato | BofA Securities | Neutral |
2023-07-25 | Ripresa | Jefferies | Buy |
2022-10-21 | Ripresa | Jefferies | Buy |
2022-07-29 | Iniziato | CapitalOne | Overweight |
2022-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2021-01-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2020-10-05 | Aggiornamento | Northland Capital | Market Perform → Outperform |
2020-05-01 | Iniziato | Northland Capital | Outperform |
2019-03-13 | Downgrade | Needham | Buy → Hold |
2019-03-13 | Downgrade | Piper Jaffray | Overweight → Neutral |
2018-08-10 | Reiterato | Needham | Buy |
2018-03-13 | Reiterato | Needham | Buy |
2017-12-01 | Reiterato | Needham | Buy |
2017-11-09 | Downgrade | Raymond James | Outperform → Mkt Perform |
2017-09-27 | Reiterato | Needham | Buy |
2017-03-14 | Downgrade | Raymond James | Strong Buy → Outperform |
2016-08-09 | Reiterato | Needham | Buy |
2016-05-10 | Reiterato | Needham | Buy |
2016-02-19 | Iniziato | Wells Fargo | Outperform |
2015-06-19 | Reiterato | Needham | Buy |
2015-06-03 | Iniziato | Raymond James | Strong Buy |
2014-07-21 | Iniziato | Needham | Buy |
Mostra tutto
Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie
Amphastar Pharmaceuticals Inc. Stock Analysis and ForecastBreakthrough profit margins - PrintWeekIndia
What drives Amphastar Pharmaceuticals Inc. stock priceExceptional stock performance - PrintWeekIndia
What analysts say about Amphastar Pharmaceuticals Inc. stockSuperior returns - Autocar Professional
Hussman Strategic Advisors Inc. Takes Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Is Amphastar Pharmaceuticals Inc. a good long term investmentFree Stock Selection - jammulinksnews.com
Teacher Retirement System of Texas Lowers Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals (AMPH) Plunges 4.98% on Strong Sell Rating - AInvest
agilon health, LifeStance Health Group, The Pennant Group, Corcept, and Amphastar Pharmaceuticals Shares Plummet, What You Need To Know - Yahoo Finance
Amphastar Unveils Plans To Quadruple US Manufacturing - insights.citeline.com
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 52-Week LowHere's What Happened - MarketBeat
Principal Financial Group Inc. Purchases 4,669 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
JPMorgan Downgrades Amphastar Pharmaceuticals (AMPH) to Neutral from Overweight, Brings PT Down to $30 - MSN
Amphastar lays out plan to quadruple manufacturing capacity at its California HQ - Fierce Pharma
What makes Amphastar Pharmaceuticals Inc. stock price move sharplyFree Premium Stock Market Reports - Newser
Why Amphastar Pharmaceuticals Inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser
Amphastar to Quadruple Domestic Manufacturing - Association for Accessible Medicines
How Amphastar Pharmaceuticals Inc. stock performs during market volatilityFree Stock Investment Discussion Area - Newser
Amphastar stock hits 52-week low at $21.47 amid challenging year - Investing.com Canada
SteelPeak Wealth LLC Buys Shares of 55,795 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar to quadruple production capacity at California headquarters By Investing.com - Investing.com Nigeria
Amphastar to quadruple production capacity at California headquarters - Investing.com Australia
Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga Headquarters - ACCESS Newswire
Amphastar Plans Massive 4X Production Boost: Major US Pharma Manufacturing Expansion Coming by 2028 - Stock Titan
When the Price of (AMPH) Talks, People Listen - news.stocktradersdaily.com
Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know - MSN
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Cambridge Investment Research Advisors Inc. - Defense World
Allspring Global Investments Holdings LLC Has $434,000 Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 12-Month LowHere's Why - MarketBeat
13 Cheap Healthcare Stocks with Huge Upside Potential - Insider Monkey
Floyd F. Petersen Sells 500 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock - MarketBeat
Illinois Municipal Retirement Fund Sells 604 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Amphastar Pharmaceuticals Inc Azioni (AMPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):